{"schema_version":"secwatch.filing_event.v1","accession":"0000105770-22-000038","form_type":"8-K","ticker":"WST","cik":"0000105770","company_name":"WEST PHARMACEUTICAL SERVICES INC","filed_at":"2022-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.819062+00:00","generated_at":"2026-06-24T07:59:12.500116+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"West Pharma adds Dr. Stephen Lockhart as director; $90K retainer + $190K RSU","bullets":["Elected July 26, 2022; Board expands to 11 members.","Dr. Lockhart, former CMO of Sutter Health, appointed to Innovation & Technology and Finance Committees.","Receives prorated $90,000 annual cash retainer and $190,000 annual RSU grant (grant date Aug 1, 2022).","Also eligible for Director Deferred Compensation Plan and standard indemnification agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0000105770-22-000038","json":"https://secwatch.observer/filing/0000105770-22-000038.json","markdown":"https://secwatch.observer/filing/0000105770-22-000038.md","text":"https://secwatch.observer/filing/0000105770-22-000038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105770/000010577022000038/0000105770-22-000038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105770/000010577022000038/wst-20220726.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T07:59:12.500116+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6bad83e67f","claim":"Stephen Lockhart was elected as Director at WEST PHARMACEUTICAL SERVICES INC.","evidence_excerpt":"On July 26, 2022, West Pharmaceutical Services, Inc. (the \"Company\") elected Stephen Lockhart, M.D., Ph.D., to its Board of Directors (the \"Board\") as its newest member.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/105770/000010577022000038/0000105770-22-000038-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}